Skip to main content

White House Picks PhRMA Lobbyist to Guide Supreme Court Pick

By July 9, 2018No Comments

Washington, D.C. – Following the White House’s announcement that former senator and current Big Pharma lobbyist Jon Kyl would be shepherding President Trump’s Supreme Court pick through the Senate, Brad Woodhouse, executive director of Protect Our Care, released the following statement:

“We already know that the biggest problem for Donald Trump’s Supreme Court pick would be their support for Trump’s position in favor of a lawsuit striking down health care protections, like those for people with pre-existing conditions. By making a Big Pharma lobbyist who has repeatedly called for repeal of the Affordable Care Act the representative of his nominee, President Trump is once again making clear where his priorities lie: with insurance and drug companies, not the 130 million Americans with a pre-existing condition.”